당뇨병성 망막병증에 대한 補陽還五湯의 효과: 체계적 문헌 고찰 및 메타분석
The Effect of Boyanghwano-tang for Diabetic Retinopathy: A Systematic Review and Meta-Analysis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives : The purpose of this study is to assess the effect of using Boyanghwano-tang(BYHWT) for diabetic retinopathy. Methods : We searched randomized controlled trials(RCTs) that used BYHWT for diabetic retinopathy in 10 databases(RISS, KISS, ScienceON, KCI, OASIS, DBpia, CNKI, Wanfang Database, PubMed, Cochrane Library) on August 12, 2023. Outcome measurements included total effective rate(TER) and visual acuity as the primary outcome measurements, and the secondary outcome measurements included fasting blood glucose(FBG), 2hPG, HbA1c, ET-1, NO, etc. The indicator of stability included adverse reactions. A meta-analysis was conducted according to TER, visual acuity, FBG. Results : A total of 8 randomized control trials were selected. The treatment group which used BYHWT showed significant improvement effects in TER and visual acuity compared to the control group which used western medicine or chinese patent medicine alone. TER: (RR: 1.22, CI 1.14 to 1.31, P=<0.00001), visual acuity: (RR: 2.06, CI 1.40 to 3.03, P=0.0002). Secondary outcome measurements including FBG also showed improvement in the treatment group compared to the control group. FBG: (MD: -0.15, CI -0.43 to 0.31, P=0.28). Adverse reactions were only mentioned in one study, which showed that no adverse reactions occurred in both the treatment and control groups. Conclusions : This study suggests that BYHWT is effective for diabetic retinopathy. However these findings should be interpreted cautiously due to the insufficient number of studies and unknown or high risk of bias in the included trials.
Abstract
Objectives : The purpose of this study is to assess the effect of using Boyanghwano-tang(BYHWT) for diabetic retinopathy. Methods : We searched randomized controlled trials(RCTs) that used BYHWT for diabetic retinopathy in 10 databases(RISS, KISS, ScienceON, KCI, OASIS, DBpia, CNKI, Wanfang Database, PubMed, Cochrane Library) on August 12, 2023. Outcome measurements included total effective rate(TER) and visual acuity as the primary outcome measurements, and the secondary outcome measurements included fasting blood glucose(FBG), 2hPG, HbA1c, ET-1, NO, etc. The indicator of stability included adverse reactions. A meta-analysis was conducted according to TER, visual acuity, FBG. Results : A total of 8 randomized control trials were selected. The treatment group which used BYHWT showed significant improvement effects in TER and visual acuity compared to the control group which used western medicine or chinese patent medicine alone. TER: (RR: 1.22, CI 1.14 to 1.31, P=<0.00001), visual acuity: (RR: 2.06, CI 1.40 to 3.03, P=0.0002). Secondary outcome measurements including FBG also showed improvement in the treatment group compared to the control group. FBG: (MD: -0.15, CI -0.43 to 0.31, P=0.28). Adverse reactions were only mentioned in one study, which showed that no adverse reactions occurred in both the treatment and control groups. Conclusions : This study suggests that BYHWT is effective for diabetic retinopathy. However these findings should be interpreted cautiously due to the insufficient number of studies and unknown or high risk of bias in the included trials.
참고문헌 (31)
- Kim HS, "Ophthalmology", pp.268~273 (2014), Ilchokak
- "Health Statistics 2021" (2022)[URL]
- "Health Statistics 2012" (2013)[URL]
- 윤정석, "무산동 안저 사진기로 진단된 당뇨망막병증 위험 요인 분석: 제5기 국민건강영양조사 자료", 대한안과학회지, 60(6), pp.555~568 (2019), 대한안과학회
- The Society of Korean Medicine Ophthalomology, Otolaryngology &Dermatology, "Text of Traditional Korean Ophthalomology", pp.171~ (2019), Globooks
- Hanuigwadaehak Bangjehak Pyeonchanwiwo nhoe, "Bangjehak", pp.414~416 (1999), Youngrimsa
- Park JH, "The Effects of Boyanghwanotang on the Thrombosis Related Factors", The Journal of Korean Oriental Internal Medicine, 21(5), pp.829~837 (2000)
- Jung WS, "Experimental study on the effects of Boyanghwanoh-tang(補陽還五湯)on blood pressure and hyperlipidemia", The Journal of Korean Oriental Internal Medicine, 18(2), pp.246~267 (1997)
- 한창호, "가미보양환오탕이 뇌허혈모델에서 신경세포보호를 통해 뇌경색억제에 미치는 효과", Journal of Acupuncture Research, 27(4), pp.29~38 (2010), 대한침구의학회
- Zhao J, "Efficacy and safety of Buyang Huanwu Decoction for early-stage diabetic nephropathy : a Meta-analysis", Zhongguo Zhong Yao Za Zhi, 44(8), pp.1660~1667 (2019)
- Zhang M, "Efficacy and safety of Buyang Huanwu decoction for diabetic peripheral neuropathy : a systematic review and Metaanalysis", The Journal of Traditional Chinese Medicine, 43(5), pp.841~850 (2023)
- Yao J, "Clinical experience of Buyang Huanwu decoction combined with mosapride in the treatment of diabetic gastroparesis", Strait Pharmacy, 32(11), pp.167~ (2020)
- Jung JH, "Clinical Study on one Patient with Vitreous Hemorrhage Caused by Diabetic Retinopathy", J Korean Med Ophthalmol Otolaryngol Dermatol, 17(2), pp.112~119 (2004)
- 이득주, "당뇨망막병증성 유리체출혈 환자 치험 1례 보고", 한방안이비인후피부과학회지, 31(2), pp.152~159 (2018), 대한한방안이비인후피부과학회[DOI]
- Zhong W, "Curative Effect Analysis of Buyang Huanwu Decoction on Non-proliferative Diabetic Retinopathy", Smart Healthcare, 30(5), pp.173~ (2019)
- Ai H, "40 cases of diabetic retinopathy treated with modified Buyang Huanwu Decoction and Liujunzi Decoction", Global Traditional Chinese Medicine, 11(10), pp.1614~1617 (2018)
- Tang H, "A review of the efficacy of Buyang Huanwu Decoction in the treatment of non-proliferative diabetic retinopathy", China Practical Medicine, 8(8), pp.172~ (2013)
- Tang A, "Effect of modified Buyanghuanwu decoction on plasma ET － 1 and NO in nonproliferative diabetic retinopathy", Proceedings of the Fourteenth National Conference of Chinese Medicine on Diabete, 28(12), pp.2328~ (2011)
- Tang A, "Influence of Buyanghuanwu decoction on hemorrheology in patients with nonproliferative diabetic retinopathy", Hebei Journal of Traditional Chinese Medicine, 29(10), pp.929~931 (2007)
- Lu Y, "Clinical effects of combined laser and oriental medicine in the treatment of type 2diabetic retinopathy", Inner Mongolia Journal of Traditional Chinese Medicine, 39(3), pp.125~ (2020)
- Yang L, "Clinical observation of Buyang Huanwu decoction combined with calcium dobesilate in treating diabetes retinopathy", CHINA'S NATUROPATHY, 27(17), pp.60~ (2019)
- Qu L, "Observations on the integrated efficacy of Oriental medicine and Western medicine in the treatment of nonproliferative diabetic retinopathy", HENAN TRADITIONAL CHINESE MEDICINE, 29(10), pp.1019~ (2009)
- Zhang X, "Calcium dobesilate for diabetic retinopathy : a systematic review and meta-analysis", Science China Life Sciences, 58(1), pp.101~107 (2015)
- Jian W, "A combination of the main constituents of Fufang Xueshuantong Capsules shows protective effects against streptozotocininduced retinal lesions in rats", Journal of Ethnopharmacology, 182, pp.50~56 (2016)
- Yau JW, "Global prevalence and major risk factors of diabetic retinopathy", Diabetes Care, 35(3), pp.556~564 (2012)
- Mansour SE, "The Evolving Treatment of Di abetic Retinopathy", Clinical Ophthalmology, 14, pp.653~678 (2020)
- Nuzzi R, "Local and systemic compl ications after intravitreal administration of a nti-vascular endothelial growth factor agents in the treatment of different ocular diseases : a five-year retrospective study", Semin Ophth almol, 30(2), pp.129~135 (2015)
- Deschler EK, "Side-effects and complications of laser treatment in diabetic retinal disease", Semin Ophthalmol, 29(5), pp.290~300 (2014)
- "MEDIC LASSICS" (2015)[URL]
- Kai Z, "Biological active ingredients of traditional Chinese herb Astragalus membranaceus on treatment of diabetes : a systematic review", Mini-Reviews in Medicinal Chemistry, 15(4), pp.315~329 (2015)
- Jin Q, "A Network Pharmacology to Explore the Mechanism of Astragalus Membranaceus in the Treatment of Diabetic Retinopathy", Evidence-Based Complementary and Alternative Medicine, 2020, pp.1~12 (2020)